CYTARAMAX 100MG

Cytaramax 100mg Injection contains Cytarabine as its active ingredient. This antineoplastic medication falls under the antimetabolite category. It is utilized either on its own or in combination with other chemotherapy drugs to treat specific forms of leukemia, which is a type of blood cancer characterized by an excess of white blood cells. This includes acute myeloid leukemia (AML) and chronic myelogenous leukemia (CML). Additionally, it is indicated for use alone or alongside other chemotherapy agents to treat and prevent meningeal leukemia, which affects the membranes that protect the spinal cord and brain.

Do not use Cytaramax 100mg Injection if you are allergic to Cytarabine or any of the other components of this medication. It is essential to inform your doctor if you experience coordination issues, are taking any other anti-cancer treatments, have reduced bone marrow function, suffer from liver conditions, or have recently undergone dialysis before or after receiving this medication.

Cytaramax 100mg Injection may lead to elevated uric acid levels in your bloodstream; your doctor will advise you if you need medication to manage this. Please notify your physician if you experience sudden allergic reactions, such as skin rash, itching, or hives, swelling of the face, lips, mouth, or throat, difficulty breathing, or wheezing. The safety of this medication in patients with kidney failure is not established, so inform your doctor if you have any kidney-related issues.